Cancer Program Advocates Seek $170 Mil. Above President’s Budget, Vow To Close Bypass Gap
In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily
NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer
Space Station Attacked By Health Research Advocates on Earth
NCI To Begin Study of Augmentation Mammoplasty This Fall
FDA Advisors Okay DDC For AIDS Treatment In Comb With AZT
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
